These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 8504502)

  • 21. Discrimination between ventricular and supraventricular tachycardia by dual chamber cardioverter defibrillators: importance of the atrial sensing function.
    Israel CW; Grönefeld G; Iscolo N; Stöppler C; Hohnloser SH
    Pacing Clin Electrophysiol; 2001 Feb; 24(2):183-90. PubMed ID: 11270697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing.
    Welte N; Strik M; Eschalier R; Mondoly P; Defaye P; Frontera A; Ritter P; Haïssaguerre M; Ploux S; Koneru J; Ellenbogen KA; Bordachar P
    Heart Rhythm; 2017 Jul; 14(7):1008-1015. PubMed ID: 28323174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new algorithm for rhythm discrimination in cardioverter defibrillators based on the initial voltage changes of the ventricular electrogram.
    Rojo-Alvarez JL; Arenal A; García-Alberola A; Ortiz M; Valdés M; Artés-Rodríguez A
    Europace; 2003 Jan; 5(1):77-82. PubMed ID: 12504645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discrimination of ventricular tachycardia from supraventricular tachycardia by a downloaded wavelet-transform morphology algorithm: a paradigm for development of implantable cardioverter defibrillator detection algorithms.
    Swerdlow CD; Brown ML; Lurie K; Zhang J; Wood NM; Olson WH; Gillberg JM
    J Cardiovasc Electrophysiol; 2002 May; 13(5):432-41. PubMed ID: 12030523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: is device implantation justified?
    Russo AM; Nayak H; Verdino R; Springman J; Gerstenfeld E; Hsia H; Marchlinski FE
    Pacing Clin Electrophysiol; 2003 Dec; 26(12):2289-95. PubMed ID: 14675014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator.
    Kelly PA; Mann DE; Damle RS; Reiter MJ
    J Am Coll Cardiol; 1994 Jun; 23(7):1531-4. PubMed ID: 8195509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new defibrillator discrimination algorithm utilizing electrogram morphology analysis.
    Gold MR; Hsu W; Marcovecchio AF; Olsovsky MR; Lang DJ; Shorofsky SR
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):179-82. PubMed ID: 9990626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a tiered therapy defibrillator system used to treat recurrent ventricular arrhythmias refractory to drugs.
    Rankin AC; Zaim S; Powell A; Zaim B; Brooks R; McGovern BA; Garan H; Ruskin JN
    Br Heart J; 1993 Jul; 70(1):61-9. PubMed ID: 8038001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implanted defibrillators in trouble: initial device misclassification leads to correct diagnosis-a case series.
    Müssigbrodt A; Knopp H; Seewöster T; Hilbert S; Lucas J; Nowotnick K; Dinov B; Hindricks G; Arya A; Richter S
    Europace; 2017 May; 19(5):795-801. PubMed ID: 27256418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensing and detection in Medtronic implantable cardioverter defibrillators.
    Brown ML; Swerdlow CD
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):193-212. PubMed ID: 27624809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of third-generation implantable cardioverter defibrillators to abort shock therapy for nonsustained ventricular tachycardia due to shortcomings of the VF confirmation algorithm.
    Grimm W; Menz V; Hoffmann J; Maisch B
    Pacing Clin Electrophysiol; 1998 Apr; 21(4 Pt 1):722-7. PubMed ID: 9584303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators.
    Schmitt C; Montero M; Melichercik J
    Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 1):295-302. PubMed ID: 7513854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator.
    Dorian P; Philippon F; Thibault B; Kimber S; Sterns L; Greene M; Newman D; Gelaznikas R; Barr A;
    Heart Rhythm; 2004 Nov; 1(5):540-7. PubMed ID: 15851216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tachyarrhythmia discriminator for implantable cardioverter-defibrillators in bundle branch block.
    Kapoor R; Tyagi S; Dohmen C; Oujiri J; Roth J; Rubenstein JC; Berger M
    Heart Rhythm; 2020 Sep; 17(9):1561-1565. PubMed ID: 32353586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failed anti-tachycardia pacing can be used to differentiate atrial arrhythmias from ventricular tachycardia in implantable cardioverter-defibrillators.
    Michael KA; Enriquez A; Baranchuk A; Haley C; Caldwell J; Simpson CS; Abdollah H; Redfearn DP
    Europace; 2015 Jan; 17(1):78-83. PubMed ID: 25031236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].
    Weber M; Block M; Brunn J; Bänsch D; Böcker D; Hammel D; Gietzen F; Breithardt G
    Z Kardiol; 1996 Nov; 85(11):809-19. PubMed ID: 9064943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable cardioverter-defibrillator.
    Grimm W; Flores BF; Marchlinski FE
    Am J Cardiol; 1993 Jun; 71(16):1415-8. PubMed ID: 8517386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.